On 19-25 May it was European Mental Health Week – a timely opportunity to shed light on an often-overlooked challenge: the emotional strain that fertility treatments place on individuals and couples. The psychological toll includes high levels of stress, anxiety, and...

As one of the first commercial partners to access the ReproUnion Biobank & Infertility Cohort (RUBIC), Caerus Biotech is collaborating with Rigshospitalet to analyze samples from 1000 men, using the company’s MiOXSYS system designed to measure oxidative stress in...

This second event organized by ReproYoung on 22 May once again filled the auditorium with an incredibly engaged audience at Medicon Valley Alliance in Copenhagen. The topic was male and female infertility – assessment and prognostic factors - featuring two insightful...

In April 2025 ReproUnion was for the first time featured in a podcast, and it was a unique opportunity to contribute to the broader debate about Denmark’s position in the global life science sector. The podcast is part of a new series inspired by the Danish Life...

On 4 March, one of the world’s leading reproductive medicine journals Human Reproduction published the findings from the largest existing study, to examine the link between semen quality and mortality. Based on data from nearly 80,000 men, the study finds that higher...